Cognizant Technology Solutions
CTSH · NASDAQ
About CTSH
- Employees
- 357,600
- Headquarters
- Teaneck, New Jersey
- Listed
- Jun 24, 1998
- Sector
- Information Technology
- Industry
- IT Services
- Website
- cognizant.com
CTSH key statistics
- Market cap
- 30.09B
- Price-earnings ratio
- 14.36
- Dividend yield
- 2.08%
- Average volume
- 6.49M
- Volume
- 3.44M
- Open price
- $67.50
- High today
- $68.75
- Low today
- $67.29
- 52 Week high
- $87.03
- 52 Week low
- $37.08
Cognizant Technology Solutions (CTSH) at a glance
As of Oct 20, 2026, Cognizant Technology Solutions (CTSH) shares are priced at $68.18, giving the company a market cap of 30.09B, a price-to-earnings ratio of 14.36 and a dividend yield of 2.08%.
Today the stock has traded between $67.29 and $68.75. The current price is 1.3% above the day's low and 0.8% below its high.
Volume so far is 3.44M shares, below the average of 6.49M shares a day.
Over the past year Cognizant Technology Solutions has ranged from $37.08 to $87.03, and now sits 62% of the way up that range.
Cognizant Technology Solutions met or beat analyst EPS estimates in 7 of the last 8 quarters. In Q2 FY26 it reported $1.37 per share against an estimate of $1.40.
The average analyst price target is $67.24, 1.4% below the current price, from 18 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy38.9%
- Hold61.1%
- Sell0.0%
- Low
- $47.47
- Now
- $68.18
- High
- $90.30
CTSH earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 7 of the last 8 quarters, by 3.3% on average.
- Q3 FY24: reported $1.25 per share against an estimate of $1.17
- Q4 FY24: reported $1.21 per share against an estimate of $1.14
- Q1 FY25: reported $1.23 per share against an estimate of $1.22
- Q2 FY25: reported $1.31 per share against an estimate of $1.29
- Q3 FY25: reported $1.39 per share against an estimate of $1.33
- Q4 FY25: reported $1.35 per share against an estimate of $1.35
- Q1 FY26: reported $1.40 per share against an estimate of $1.36
- Q2 FY26: reported $1.37 per share against an estimate of $1.40
CTSH news
- Press releasePRNewswire
- Press releasePRNewswire
Cognizant and Google Cloud Expand Alliance to Accelerate Agentic Enterprise Transformation
- Namrata Sen
JD Vance Defends Trump’s Visa Crackdown, Says Bernie Sanders Once Echoed Stephen Miller on Open Borders: ‘It is Ironic’
- Press releasePRNewswire
80% of Employees Want to Use AI More Than Their Jobs Allow
- Surbhi Jain
Microsoft's Visa Freeze Could Trigger an AI 'Brain Drain'
- Press releasePRNewswire
Cognizant Expands AI-Enabled DevOps Capabilities for Gilead Sciences
- Press releasePRNewswire
Belcan Receives Pratt & Whitney Premier Awards for Overall Excellence in Business Management and Technology & Innovation
- Press releasePRNewswire
Cognizant Selected by SITA to Deliver AI-Led Global Finance Transformation on the Cloud
Similar companies
Companies in the same industry as Cognizant Technology Solutions
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- FRTTFort Technology$0.7121+32.63%
- SDSTStardust Power$0.02−23.66%
- CBDLCBD Life Sciences$0.0002−25.00%
- MDEXMadison Technologies$0.0005−37.50%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.